[Augmentation of the action of antidiabetic pharmaceutic products due to the use of monoamine oxidase inhibitors and beta blockaders].
D003920:Diabetes Mellitus / Q000188:drug therapy*; D004357:Drug Synergism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D013565:Sympatholytics / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D008996:Monoamine Oxidase Inhibitors; D013565:Sympatholytics
Augmentation de l'action des produits pharmaceutiques antidiabétiques due à l'emploi des IMAO et des béta-bloquants.